Advertisement

Index by author

February 01, 2012; Volume 340,Issue 2

  1. Bakajsova, Diana

    1. γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
      Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882

  2. Baker, Dale

    1. Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441

  3. Beger, Richard

    1. Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948

  4. Benavidez, Jill M.

    1. Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
      Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124

  5. Betz, Andreas

    1. Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441

  6. Blednov, Yuri A.

    1. Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
      Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124
    2. Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116

  7. Blobaum, Anna L.

    1. The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443

  8. Bode, Jacob

    1. The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443

  9. Borghese, Cecilia M.

    1. Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116

  10. Bridges, Thomas M.

    1. The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
« Previous (Pages : 1 2 3 4 5 6 7 ... 20) Next »
Back to top

In this issue

Advertisement